EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical and radiological features of fifteen patients presenting with concentric lesions like Baló's concentric sclerosis

Kazunori Iwao, Katsuhisa Masaki, Koji Shinoda, Mitsuru Watanabe, Yuu-ichi Kira, Eizo Tanaka, Hajime Takeuchi, Ayano Matsuyoshi, Yukiko Inamori, Kazufumi Kikuchi, Koji Yamashita, Osamu Togao und 1 weitere

Multiple Sclerosis Journal – Experimental, Translational and Clinical · 2026-10 · 12 (4)

DOI: 10.1177/20552173261480994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Multiple Sclerosis Journal – Experimental, Translational and Clinical, online erschienen am 13.11.2026. Verfasst von Kazunori Iwao und 12 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MHLW Research Program on Rare and Intractable Diseases, Japan Society for the Promotion of Science.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Baló's concentric sclerosis (BCS) is a rare demyelinating disorder defined by alternating rings of demyelinated and preserved myelin.

Methods

We retrospectively reviewed the medical records of 15 Japanese patients with BCS lesions seen at our institution over a 15-year period.

Results

The median age at onset was 29 years, with a female predominance (67%). All patients fulfilled the 2024 McDonald criteria for multiple sclerosis (MS), and 83% exhibited cerebrospinal fluid oligoclonal bands (OCBs). In patients who underwent susceptibility-weighted imaging, peripheral hypointensity was frequently observed, whereas classic lamellar architecture was not clearly visualized. Over long-term follow-up, new BCS lesions were detected during treatment with interferon beta, dimethyl fumarate, fingolimod, or siponimod, whereas no new BCS lesions were observed during natalizumab or ofatumumab exposure, except shortly after switching to natalizumab.

Conclusions

These findings support the concept that BCS constitutes a clinical variant within the MS spectrum. Some patients appeared to benefit from natalizumab or ofatumumab, although the optimal DMT remains uncertain. The frequent presence of OCBs and MS-like radiological features may indicate overlap with classical MS. BCS may thus represent a common and distinct immune-mediated demyelinating phenotype at the interface between classical MS and atypical demyelination.

Förderung

  • MHLW Research Program on Rare and Intractable Diseases
  • Japan Society for the Promotion of Science

Zitieren

APA

Iwao, K., Masaki, K., Shinoda, K., Watanabe, M., Kira, Y., Tanaka, E., Takeuchi, H., Matsuyoshi, A., Inamori, Y., Kikuchi, K., Yamashita, K., Togao, O., & Isobe, N. (2026). Clinical and radiological features of fifteen patients presenting with concentric lesions like Baló's concentric sclerosis. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 12(4). https://doi.org/10.1177/20552173261480994

Vancouver

Iwao K, Masaki K, Shinoda K, Watanabe M, Kira Y, Tanaka E, et al. Clinical and radiological features of fifteen patients presenting with concentric lesions like Baló's concentric sclerosis. Multiple Sclerosis Journal – Experimental, Translational and Clinical. 2026;12(4). doi:10.1177/20552173261480994

BibTeX
@article{Iwao2026,
  author = {Iwao, Kazunori and Masaki, Katsuhisa and Shinoda, Koji and Watanabe, Mitsuru and Kira, Yuu-ichi and Tanaka, Eizo and Takeuchi, Hajime and Matsuyoshi, Ayano and Inamori, Yukiko and Kikuchi, Kazufumi and Yamashita, Koji and Togao, Osamu and Isobe, Noriko},
  title = {Clinical and radiological features of fifteen patients presenting with concentric lesions like Baló's concentric sclerosis},
  journal = {Multiple Sclerosis Journal – Experimental, Translational and Clinical},
  year = {2026},
  volume = {12},
  number = {4},
  doi = {10.1177/20552173261480994}
}
Kostenlos starten →